Dual antiplatelet therapy — treatment with the medications clopidogrel and aspirin together to prevent blood clots — poses a clinically significant risk of hemorrhage that should be considered before prescribing, according to a new report.
Dual antiplatelet therapy — treatment with the medications clopidogrel and aspirin together to prevent blood clots — poses a clinically significant risk of hemorrhage that should be considered before prescribing, according to a new report.